Invention Grant
- Patent Title: Folate receptor targeted nanoparticle drug conjugates and uses thereof
-
Application No.: US17867025Application Date: 2022-07-18
-
Publication No.: US11744897B2Publication Date: 2023-09-05
- Inventor: Kai Ma , Aranapakam M. Venkatesan , Feng Chen , Fei Wu , Melik Ziya Türker , Thomas Courtney Gardinier, II , Geno J. Germano, Jr. , Gregory Paul Adams , Francis Y. F. Lee
- Applicant: Elucida Oncology, Inc.
- Applicant Address: US NJ Monmouth Junction
- Assignee: Elucida Oncology, Inc.
- Current Assignee: Elucida Oncology, Inc.
- Current Assignee Address: US NJ Monmouth Junction
- Agency: Hogan Lovells US LLP
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K47/55 ; A61K47/54 ; A61K47/69 ; A61K47/60 ; A61P35/00 ; A61K49/00
Abstract:
The disclosure relates to nanoparticle drug conjugates (NDC) that comprise ultrasmall nanoparticles, folate receptor (FR) targeting ligands, and linker-drug conjugates, and methods of making and using them to treat cancer.
Public/Granted literature
- US20220378924A1 FOLATE RECEPTOR TARGETED NANOPARTICLE DRUG CONJUGATES AND USES THEREOF Public/Granted day:2022-12-01
Information query
